Visiomed Group SA

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: FR0013481835
EUR
0.23
0 (-1.05%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

N/A

Shareholding

FII

N/A

DII

N/A

Promoter

N/A

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard
Icon
Unrated Stock - No Analysis Available
stock-summaryMojo Parameters
Mojo Parameters
Stock DNA
stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

EUR 75 Million ()

stock-summary
P/E

36.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

0.09

stock-summary
Return on Equity

8.89%

stock-summary
Price to Book

2.74

Revenue and Profits:
Net Sales:
4 Million
(Quarterly Results - Jun 2012)
Net Profit:
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
3.99%
0%
3.99%
6 Months
34.46%
0%
34.46%
1 Year
42.99%
0%
42.99%
2 Years
-23.06%
0%
-23.06%
3 Years
-47.3%
0%
-47.3%
4 Years
117.33%
0%
117.33%
5 Years
-75.65%
0%
-75.65%

Visiomed Group SA for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions
News
Icon
No Recent News for the Company
Announcements stock-summary
Icon
No announcement available
Corporate Actions stock-summary
Icon
No corporate action available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
13.05%
EBIT Growth (5y)
16.17%
EBIT to Interest (avg)
-6.54
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
0.09
Sales to Capital Employed (avg)
-0.04
Tax Ratio
17.80%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
0.37%
ROE (avg)
1.75%
Valuation key factors
Factor
Value
P/E Ratio
36
Industry P/E
Price to Book Value
3.24
EV to EBIT
40.37
EV to EBITDA
29.43
EV to Capital Employed
3.24
EV to Sales
4.26
PEG Ratio
0.74
Dividend Yield
NA
ROCE (Latest)
8.02%
ROE (Latest)
8.89%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Mildly Bullish
RSI
Bearish
No Signal
Bollinger Bands
Bearish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
Mildly Bearish
No Trend
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshotstock-summary
Icon
No data for shareholding present.
Shareholding Compare (%holding) stock-summary
Icon
No data for shareholding present.
stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "alert": "No Quarterly Results declared by Visiomed Group SA"
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is 26.28% vs -4.86% in Dec 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is 55.56% vs 116.98% in Dec 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "17.30",
          "val2": "13.70",
          "chgp": "26.28%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "2.20",
          "val2": "1.20",
          "chgp": "83.33%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.80",
          "val2": "1.20",
          "chgp": "-33.33%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "1.40",
          "val2": "0.90",
          "chgp": "55.56%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "32.40%",
          "val2": "-55.20%",
          "chgp": "8.76%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]
Annual Results Snapshot (Consolidated) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
17.30
13.70
26.28%
Operating Profit (PBDIT) excl Other Income
2.20
1.20
83.33%
Interest
0.80
1.20
-33.33%
Exceptional Items
0.00
0.00
Consolidate Net Profit
1.40
0.90
55.56%
Operating Profit Margin (Excl OI)
32.40%
-55.20%
8.76%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in year ended Dec 2024 is 26.28% vs -4.86% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2024 is 55.56% vs 116.98% in Dec 2023

stock-summaryCompany CV
About Visiomed Group SA stock-summary
stock-summary
Visiomed Group SA
Pharmaceuticals & Biotechnology
Visiomed Group SA is a France-based company engaged in the design, manufacture and marketing of medical electronics. It develops and markets health products in the fields of medical and well-being self-diagnosis to provide non-drug prevention and treatment solutions. The Company's product portfolio comprises MyThermo, an infrared contact-less medical thermometer; MyTension, an automatic blood pressure and pulse monitors; MyOxy, a finger pulse oximeter; MyECG, a pocket electrodiogram; MyGluco, a blood sugar meter; My Coach, a health and fitness coach, and Epiderm, a telemedicine dermatology mobile application, among others. The Company sells its products to pharmacies, health professionals (hospitals, clinics and retirement homes) and to retail chains. Its brand names include ThermoFlash and BewellConnect, among others.
Company Coordinates stock-summary
Company Details
112, Avenue Kleber , PARIS None : 75116
stock-summary
Tel: 33 1 40670650
stock-summary
Registrar Details